XTSE
PRM
Market cap13mUSD
Oct 08, Last price
14.55CAD
1D
1.61%
1Q
-1.02%
IPO
0.34%
Name
Big Pharma Split Corp
Chart & performance
P/E
—
P/S
—
EPS
3.37
Div yield, %
8.50%
Shrs. gr., 5y
4.23%
Rev. gr., 5y
-13.95%
Revenues
1m
-21.38%
Net income
4m
P
CFO
-1m
L-18.56%
Dividend
Sep 29, 20260.1031 CAD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Big Pharma Split Corp, a closed-end equity investment fund, was established on September 15, 2017, and maintains its domicile in Canada. Overseen by Harvest Portfolios Group Inc., the fund concentrates its investments primarily within the pharmaceutical sector, targeting publicly traded companies across the United States.
Related entities
Parent
HARVEST PORTFOLIOS GROUP INC.
IPO date
Nov 23, 2017
Employees
Domiciled in
CA
Incorporated in
CA
Legal address
C/O HARVEST PORTFOLIOS GROUP INC.
610 Chartwell Road
Suite 204
Oakville, ON L6J 4A5
CA
610 Chartwell Road
Suite 204
Oakville, ON L6J 4A5
CA
Headquarters
610 Chartwell Road
Suite 204
OAKVILLE, ON L6J 4A5
CA
Suite 204
OAKVILLE, ON L6J 4A5
CA
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT |